financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Adss Of Vodafone
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Adss Of Vodafone
May 17, 2024 3:06 AM

05:45 AM EDT, 05/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our Hold recommendation on shares of Vodafone ( VOD ) with a higher target price of USD10.0 (from USD9.5). This represents FY25 (Mar.) consensus EV/EBITDA of 6.5x, which is similar to the valuation of its large telco peers. We deem the valuation as fair as it balances VOD's improving EBITDA margin trend with macro headwinds. In FY 24, VOD total revenues declined by 2.5% to EUR36.7 billion even as service revenues grew 6.3% organically (+3.7% excluding the hyperinflation impact in Turkey) in the year. FY 24 adjusted EBITDAaL increased 2.2% organically to EUR11,019 million with a 3.0%-pts decline in the margin to 30.0%, on higher energy costs. VOD is guiding for FY 25 EBITDAaL around EUR11 billion based on stable exchange rates. We expect slight growth in EBITDAaL in FY 25 with cost controls and the discontinuation of the more troubled markets supporting results. Our FY 25 and FY 26 EPS estimates are EUR0.9 and EUR1.0, respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Wix.com Ltd.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Wix.com Ltd.
Nov 23, 2025
12:50 AM EST, 11/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our revised target price of $140 (from $200) implies a 2026 P/E of 17.9x (five-year mean: 48.7x), based on our projected slower but still strong two-year revenue CAGR of 13%...
Research Alert: CFRA Lowers Opinion On Shares Of Globus Medical To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Globus Medical To Hold From Buy
Nov 24, 2025
10:25 AM EST, 11/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $20 to $90, based on 22.5x our FY 26 EPS estimate and in line with the company's three-year average forward P/E multiple. We...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
Nov 21, 2025
02:55 PM EST, 11/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price by CAD1 to CAD70, reflecting a combination of our relative valuation and DCF model analyses. On a relative basis, we apply an 11.8x multiple...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
Nov 21, 2025
03:05 PM EST, 11/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price remains USD50, reflecting a combination of our relative valuation and DCF model analyses. On a relative basis, we apply an 11.8x multiple of enterprise value to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved